The Discounted Cash Flow (DCF) valuation of Supernus Pharmaceuticals Inc (SUPN) is 15.03 USD. With the latest stock price at 26.91 USD, the upside of Supernus Pharmaceuticals Inc based on DCF is -44.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.6% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 10.66 - 29.52 | 15.03 |
| Upside | -60.4% - 9.7% | -44.1% |